SREBF1 and fatty liver disease: The dysregulation of mTOR promotes hepatic steatosis through SREBP-mediated lipogenesis, while liver-specific PPDPF deletion induces spontaneous fatty liver by negatively regulating the mTORC1-S6K-SREBP1 signaling pathway [130].